Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.08.27.609831

Modeling Decision-Making Under Uncertainty with Qualitative Outcomes

Korem, N.·Duek, O.·Jia, R.·Wertheimer, E.·Metviner, S.·Grubb, M.·Levy, I.
View original source ↗Export metadata ↓

Abstract

Modeling decision-making under uncertainty typically relies on quantitative outcomes. Many decisions, however, are qualitative in nature, posing problems for traditional models. Here, we aimed to model uncertainty attitudes in decisions with qualitative outcomes. Participants made choices between certain outcomes and the chance for more favorable outcomes in quantitative (monetary) and qualitative (medical) modalities. Using computational modeling, we estimated the values participants assigned to qualitative outcomes and compared uncertainty attitudes across domains. Our model provided a good fit for the data, including quantitative estimates for qualitative outcomes. The model outperformed a utility function in quantitative decisions. Additionally, we found an association between ambiguity attitudes across domains. Results were replicated in an independent sample. We demonstrate the ability to extract quantitative measures from qualitative outcomes, leading to better estimation of subjective values. This allows for the characterization of individual behavior traits under a wide range of conditions. Author SummaryIn the current study, we explored how people make decisions when the outcomes arent easily measured in numbers, such as in medical choices. Traditional mathematical models, which rely on numerical data, often fall short in these situations, leading to a gap in understanding how people evaluate these qualitative outcomes. Using hierarchical Bayesian modeling, we developed a model that bridges this gap by translating qualitative outcomes into individualized quantitative values, enabling us to better understand the underlying decision-making processes. Our model not only provides a better fit to real-world data than existing models with qualitative or quantitative outcomes but also allows for meaningful comparisons of how people handle uncertainty across different decision-making scenarios. This approach opens new doors for studying decision-making in areas where traditional methods struggle, offering a more nuanced view of human behavior in complex situations.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Korem, N., Duek, O., Jia, R., Wertheimer, E., Metviner, S., Grubb, M., Levy, I.. 2024-08-28. Modeling Decision-Making Under Uncertainty with Qualitative Outcomes. https://doi.org/10.1101/2024.08.27.609831

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗